Selectis Health, Inc. (GBCS) Return on equity 2017–2022
Selectis Health, Inc. (GBCS) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-251.4%FY2022 · since FY2017: -121.5% → -251.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -251.4% | -178.8 pp |
| FY2021 | -72.6% | -159.2 pp |
| FY2020 | 86.6% | +237.4 pp |
| FY2019 | -150.8% | +17.6 pp |
| FY2018 | -168.4% | -46.9 pp |
| FY2017 | -121.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice